Slide 1: Exchange filing cover letter: Investor Presentation
RPG LIFE SCIENCES LIMITED Regd. Off.: RPG House 463, Dr. Annie Besant Road Worli, Mumbai 400030, India Tel: +91-22-24981650 / 66606375 Fax: +91-22-24970127 Email: info@rpglifesciences.com RPG LIFE SCIENCES www.rpglifesciences.com CIN : L24232MH2007PLC169354 July 29, 2023 To The Manager BSE Limited L
Slide 2: Investors' Presentation Q1 FY24
RPG LIFE SCIENCES An ~>>R,::.c:; Company Investors’ Presentation Q1 FY24
Slide 3: Disclaimer
Disclaimer This presentation may include statements which may constitute forward-looking statements. All statements that address expectations or projections about the future, including, but not limited to, statements about the strategy for growth, business development, market position, expenditures,
Slide 4: RPG Group: One of India's fastest-growing diversified conglomerates
RPG Group: One of India's fastest-growing diversified conglomerates UN -EA,SHTALENT RPG Group has a business history dating back to 1820 AD in banking, textiles, jute, and tea. RPG Enterprises was founded in 1979 and currently operates in various businesses TOUCH LIVES in Infrastructure, Technology,
Slide 5: An Integrated Pharmaceutical Company – APIs to Formulations
RPG Life Sciences: An Integrated Pharmaceutical Company –APIs to Formulations; R&D to Manufacturing to Marketing RPG Life Sciences, part of RPG Enterprises, is an integrated research based pharmaceutical company operating in the domestic and international markets in the branded formulations, global
Slide 6: RPG Life Sciences Product Portfolio
RPG Life Sciences Product Portfolio: Strong ‘Textbook’ brands being augmented by Diligent Life Cycle Management and New Launches in Chronic and Specialty therapies Key Therapies Key Products Legacy Portfolio New Portfolio Nephrology Immunosuppressants Text Book Brands Specialty Chronic Life Cycle Ma
Slide 7: Financial Performance
Financial Performance An <l>» RPCi Company 6 L R?G LIFE SCIENCES
Slide 8: Journey of RPG Life Sciences
Journey of RPG Life Sciences 1 2 Process Excellence Product Portfolio, People, Business Processes Fundamentals Fixation Sales Hygiene, People, Organization 3 Sustainable Profitable Growth Revenues, Volumes, Margins 4 Benchmark 5 Performance Profitability, Leverage, Liquidity Ratios Scale-up An <l>»
Slide 9: Margins: A Trajectory of y-o-y Expansion despite Market Challenges
Margins: A Trajectory of y-o-y Expansion despite Market Challenges EBITDA:10.4% (FY19) to 23.0%(Q1 FY24);PBT: 4.6% (FY19) to 20.1%(Q1 FY24);PAT: 3.3% (FY19) to 15.0% (Q1 FY24) EBITDA% 23.0% 20.3% 21.0% PBT% 18.2% 20.1% 16.6% 17.9% 15.9% PAT% 13.8% 15.0% 11.7% 13.2% 11.1% 11.1% 10.4% 10.3% 9.8% 9.3%
Slide 10: Q1 FY24: Yet Another Strong Quarter
Q1 FY24 : Yet Another Strong Quarter (All figures in Rs. Crores except EPS in Rs.) Revenue from Operations EBITDA & EBITDA Margin PBT & PBT Margin ---t 147.8 128.9 29.1 p 34.0 25.1 29.8 n22.5% Q1 FY23 •23.0% Q1 FY24 19.5% Q1 FY23 20.1% Q1 FY24 Q1 FY23 Q1 FY24 PAT & PAT Margin EPS - -t -t 22.1 13.4 1
Slide 11: Key Financials' Trends
Key Financials’ Trends (All figures in Rs. Crores except EPS in Rs.) Revenue from Operations - --t ___t EBITDA & EBITDA Margin PBT & PBT Margin - -t 107.5 91.7 512.8 440.2 89.4 73.2 375.6 389.1 70.8 330.2 59.9 53.6 41.8 ' 147.8 34.4 34.1 29.8 15.1 □ □ 10.4% 15.9% 18.2% 20.3% 21.0% 23.0% 4.6% 11.1% 1
Slide 12: Key Ratios (ROCE, ROE, D/E): A Trajectory of y-o-y uptrend
Key Ratios (ROCE, ROE, D/E) : A Trajectory of y-o-y uptrend _f ROCE% _f ROE% Debt/Equity Ratio - -l 22.0% 0.22 28.5% 29.7% 18.5% 20.1% 24.9% 16.4% 20.9% 9.7% 6.7% 0.06 0.01 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 - FY21 0.00 FY22 0.00 FY23 Company continues to remain Debt-free An
Slide 13: Business Segment-wise Performance: Q1 FY24
Business Segment-wise Performance: Q1 FY24 • Domestic Formulations contributed 66% to total sales of Q1 FY24 97.4 Domestic • 16% sales growth majorly driven by legacy products 83.9 Formulations • Better than market growth (DF) • New products* contribution improving consistently (currently >20%) on a
Slide 14: RPG Life Sciences ICRA Rating Reaffirmed in FY23
RPG Life Sciences ICRA Rating Reaffirmed in FY23 Long term rating reaffirmed at A Short term rating reaffirmed at A1 Outlook on long term rating has been retained as Stable The rating reaffirmation factors: Strong brands in the Indian Pharmaceutical Industry Considerable improvement in the opera
Slide 15: Business Strategy
Business Strategy An <l>» RPCi Company 14 L R?G LIFE SCIENCES
Slide 16: Domestic Formulations (DF)
Domestic Formulations (DF) • Operating in Mass/Mass-specialty and Specialty segments • Presence in both Acute & Chronic therapy areas • Leading Text Book Brands – Azoran, Aldactone, Lomotil, Naprosyn, Serenace, Norpace • Leading player in Immunosuppressant category • Good customer coverage - Cardiol
Slide 17: International Formulations (IF) Business: Overview and Strategy
International Formulations (IF) Business: Overview and Strategy • Strong presence in immunosuppressant segment (Azathioprine) • Footprints across Regulated and Emerging markets - Canada, UK, Germany, France, Australia, South East Asia, Africa • Long lasting, impeccable supply track record and busine
Slide 18: APIs Business: Business Strategy and Way Forward
APIs Business: Business Strategy and Way Forward • High value, low volume, niche APIs • Footprints across geographies - LATAM, Germany, China, South • Mature stable molecules Korea, Iran, Bangladesh, Egypt, India, etc. • Provides backward integration to International • Strong customer focus – long-l
Slide 19: Infrastructure & Backend Capabilities
Infrastructure & Backend Capabilities An <l>» RPCi Company 18 L R?G LIFE SCIENCES
Slide 20: Manufacturing Facilities
Manufacturing Facilities Formulations Unit 1, Ankleshwar • F1 unit caters to the domestic and emerging markets • Multipurpose plant with dedicated product lines for oral dosage forms including tablets, liquids and powder • WHO, Kenya, Nigeria approved Formulations Unit 2, Ankleshwar • F2 unit caters
Slide 21: Strong Backend Capabilities
Strong Backend Capabilities Quality Regulatory • All critical SOPs harmonized through CQA • Well established & evolved Regulatory function catering • Quarterly internal audit of all plants by CQA to Canada, UK, EU, Australia and emerging markets • All critical deviations, change controls and market
Slide 22: Operational Highlights
Operational Highlights An <l>» RPCi Company 21 L R?G LIFE SCIENCES
Slide 23: Top Operational Highlights
Top 10 Operational Highlights Comprehensive Life Cycle Management Strategy for DF Legacy product Naprosyn becomes the first 60 Cr+ Brand in FY23; 1 Legacy products yielding results Crosses 19 Cr Mark in FY24 Q1 New Product portfolio across identified segments 2 contributing healthy double-digit grow
Slide 24: Digitalization Initiatives to Transform Business
Digitalization Initiatives to Transform Business Game Changer Customer Connect Initiative Employee Connect Initiatives Digital Platform for comprehensive ~ 2 .0 Salesforce Operations tracking: #Customer visits, customer engagement activities, sales performance analytics etc .- • Anytime, Anywhere Do
Slide 25: People Initiatives to build Performance Culture with focus on Happiness
People Initiatives to build Performance Culture with focus on Happiness I Love My Work I Feel Valued RPGLS Heroes I am Growing ~ Outperformance ~ recognition We Skill. You Grow. Competency building You Excel. We Applaud. continuum Motivation continuum •• Akanksha High 0 Career development Happiness
Slide 26: Initiatives for building a Performance Driven Culture: Glimpses
Initiatives for building a Performance Driven Culture: Glimpses Skilling Rewards & Recognition Employee engagement: Parivar Tyohar Utsav Employee Connect Idea Generation An <l>» RPCi Company
Slide 27: Monthly Townhall for Connect, Recognition and Camaraderie: Glimpses
Happiness Initiative: Hello Happiness Forum Monthly Townhall for Connect, Recognition and Camaraderie: Glimpses •• For Your Happiness @ RPCi L I FE SCIENCES • 0 hello happiness • \..J • • RPGLS Happiness Forum \J · Rewards & Recognition --~ Monthly Townhall for Connect, Recognition hello happiness a
Slide 28: Virtual Celebration of Festivals with Families: Glimpses
Happiness Initiative: Parivar Tyohar Utsav Shrankhla Virtual Celebration of Festivals with Families: Glimpses •• For Your Happiness @ R?G L I FE SCIENCES • 0 hello happiness \....,I ii¢filt-ii¢3i ~ • • RPGLS Parivar Tyohar-Utsav Shrankhla Virtual Celebration of Festivals with Families " I loved thes
Slide 29: Awards & Recognitions
Awards & Recognitions An <l>» RPCi Company 28 L R?G LIFE SCIENCES
Slide 30: RPG Life Sciences Bagged Top Awards from IDMA
RPG Life Sciences Bagged Top Awards from IDMA Industry Recognition to RPG Life Sciences Best Patent Award Best Corporate Citizen Award An <l>» RPCi Company L R?G LIFE SCIENCES
Slide 31: Jamnalal Bajaj Award for Fair Business Practices
RPG Life Sciences Awarded with ‘Jamnalal Bajaj Award for Fair Business Practices’ Jamnalal Bajaj Award for Fair Business Practices (2021-22) An <l>» RPCi Company L R?G LIFE SCIENCES
Slide 32: New Launch Naprosyn+ bags Brand Champion of the Year Award
New Launch Naprosyn+ bags Brand Champion of the Year Award 1 SILVER IM- _ D I RO "DLY .IPll , S, . Naprosyn+ An <l>» RPCi Company L R?G LIFE SCIENCES
Slide 33: Thank You
T H A N K Y O U An <l>» RPCi Company L R?G LIFE SCIENCES